8-K//Current report
BridgeBio Pharma, Inc. 8-K
Accession 0001140361-25-024413
$BBIOCIK 0001743881operating
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 1, 5:42 PM ET
Size
161.7 KB
Accession
0001140361-25-024413
Documents
- 8-Kef20051467_8k.htmPrimary
8-K
- EX-101.SCHbbio-20250627.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABbbio-20250627_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREbbio-20250627_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001140361-25-024413-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLef20051467_8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001743881
Filing Metadata
- Form type
- 8-K
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 1, 5:42 PM ET
- Size
- 161.7 KB